Flu test kit RIDA®GENE

influenza Ainfluenza Bclinical

For in vitro diagnostic use. The RIDA®GENE Flu test, performed on the Roche LightCycler® 480II, is a multiplex real-time RT-PCR for the direct qualitative detection and differentiation of influenza virus RNA (influenza A, influenza B, and H1N1v) in untreated human nasal/throat swabs from persons with signs and symptoms of acute respiratory infection. The RIDA®GENE Flu test is intended to support the differential diagnosis of influenza virus infections in patients with symptoms of respiratory infection in connection with other clinical and laboratory findings. Negative results do not rule out infection with influenza virus and should not be used as the sole basis for diagnosis. The product is intended for use by professionals working in hospital laboratories, reference laboratories, private laboratories, or public laboratories. General information: Also called the flu, influenza is one of the most significant infectious respiratory diseases, and it is caused by influenza viruses. Worldwide three to five million people contract influenza every year, and approximately 290,000 to 650,000 people die from the illness. The annual influenza epidemics can have major impacts on the health care system and the economy. In the 2018/19 season, estimates put the number of influenza-related doctor’s visits in Germany at about 3.8 million. The number of influenza-related hospitalizations from primary care practices was estimated at 18,000 cases. The Working Group on Influenza (AGI) of the Robert Koch Institute estimates there are between one and seven million influenza-related doctor’s visits each year.